Cognition Therapeutics Inc
CGTX
Revenue
0.00
0.000.00%
-Assets
34.37M
▼-4.48M▼-11.54%
3 Months ChangeLiabilities
11.36M
▲1.37M▲13.70%
3 Months ChangeFree Cash Flow
-2.75M
▲376.00k▲12.04%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001104659-24-104541
2024-09-13
Form 8-K
ID: 0001104659-24-099746
2024-08-28
Form 8-K
ID: 0001104659-24-093660
2024-08-08
Form 10-Q
ID: 0001558370-24-011464
2024-08-08
Form 8-K
ID: 0001104659-24-087001
2024-07-29
Form 8-K
ID: 0001104659-24-083280
2024-06-07
Form 8-K
ID: 0001104659-24-069635
2024-05-07
Form 10-Q
ID: 0001558370-24-006911
2024-05-07
Form 8-K
ID: 0001104659-24-057711
2024-03-26
Form 8-K
ID: 0001104659-24-038686